Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer

Cancer Gene Therapy

Volumn 13, Issue 9, 2006, Pages 856-863

  Oshikiri, T ^a   Miyamoto, M ^a   Hiraoka, K ^a,b   Shichinohe, T ^a   Kawarada, Y ^a   Kato, K ^a   Suzuoki, M ^a   Nakakubo, Y ^a   Kondo, S ^a   Dosaka Akita, H ^a   Kasahara, N ^b   Katoh, H ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Gene therapy; Lung cancer; Squamous cell carcinoma; Targeting

Indexed keywords

ADENOVIRUS VECTOR; BIOCHEMICAL MARKER; CYTOCHROME C; GREEN FLUORESCENT PROTEIN; LUCIFERASE; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FLANKING REGION; GENE; GENE INDUCTION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG CANCER; MALE; MARKER GENE; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SCCA2 GENE; SQUAMOUS CELL CARCINOMA; SUICIDE GENE; TRANSCRIPTION REGULATION;

ADENOVIRIDAE; ANTIGENS, NEOPLASM; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DNA PRIMERS; GENE TARGETING; GENE THERAPY; GENETIC VECTORS; HUMANS; IN SITU NICK-END LABELING; LUCIFERASES; LUNG NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS;

ADENOVIRIDAE;

EID: 33747224775     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700953     Document Type: Article

References (27)

1. Levi F, Lucchini F, Negri E, La Vecchia C. Worldwide patterns of cancer mortality, 1990-1994. Eur J Cancer Prev 1999; 8: 381-400.
2. Ginseberg R, Vokes E, Raben A. Cancer of the lung: non-small-cell lung cancer. In: De Vita V, Hellman S, Rosenberg S (eds). Cancer: Principles and Practice of Oncology, 5th edn. Lippincott: Philadelphia, 1997, pp 858-911.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2001; 51: 15-36.
4. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I et al. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 1994; 54: 5258-5261.
5. Takeuchi M, Shichinohe T, Senmaru N, Miyamoto M, Fujita H, Takimoto M et al. The dominant-negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice. Gene Ther 2000; 7: 518-526.
6. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40: 1621-1628.
7. Takeshima N, Suminami Y, Takeda O, Abe H, Okuno N, Kato H. Expression of mRNA of SCC antigen in squamous cells. Tumour Biol 1992; 13: 338-342.
8. Sanchez De Cos J, Masa F, de la Cruz JL, Disdier C, Vergara C. Squamous cell carcinoma antigen (SCC Ag)in the diagnosis and prognosis of lung cancer. Chest 1994; 105: 773-776.
9. Cheah PL, Liam CK, Yap SF, Looi LM. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung. J Clin Pathol 1994; 47: 535-537.
10. Mino N, Iio A, Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988; 62: 730-734.
11. Bolli JA, Doering DL, Bosscher JR, Day Jr TG, Rao CV, Owens K et al. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1994; 55: 169-173.
12. Kato H, Nagaya T, Torigoe T. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation. Gann 1984; 75: 433-435.
13. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995; 92: 3147-3151.
14. Murakami A, Suminami Y, Sakaguchi Y, Nawata S, Numa F, Kishi F et al. Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCR. Tumour Biol 2000; 21: 224-234.
15. Abe H, Okuno N, Takeda O, Suminami Y, Kato H, Nakamura K. Analysis on heterogeneity of squamous cell carcinoma antigen by two-dimensional electrophoresis. Electrophoresis 1994; 15: 988-991.
16. Stenman J, Hedstrom J, Grenman R, Leivo I, Finne P, Palotie A et al. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer 2001; 95: 39-43.
17. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA et al. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 1997; 272: 1849-1855.
18. Sakaguchi Y, Kishi F, Murakami A, Suminami Y, Kato H. Structural analysis of human SCC antigen 2 promoter. Biochim Biophys Acta 1999; 1444: 111-116.
19. Hamada K, Shinomiya H, Asano Y, Kihana T, Iwamoto M, Hanakawa Y et al. Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter. Biochim Biophys Acta 2001; 1518: 124-131.
20. Javadpour MM, Juban MM, Lo WC, Bishop SM, Alberty JB, Cowell SM et al. De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 1996; 39: 3107-3113.
21. Ellerby HM, Arap W, Ellerby LM, Kain R, Andrusiak R, Rio GD et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999; 5: 1032-1038.
22. Mai JC, Mi Z, Kim SH, Ng B, Robbins PD. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 2001; 61: 7709-7712.
23. Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F et al. Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998; 72: 4756-4764.
24. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
25. Hitt M, Bett AJ, Addison C, Prevec L, Graham FL. Techniques for human adenovirus vector construction and characterization. In: Adolph K (ed). Methods in Molecular Genetics. Elsevier Science & Technology Books: San Diego, Academic Press, 1995, pp 13-30.
26. Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20-23.
27. Kagawa S, Pearson SA, Ji L, Xu K, McDonnell TJ, Swisher SG et al. A binary adenoviral vector system for expressing high levels of the proapoptotic gene bax. Gene Ther 2000; 7: 75-79.